Button to scroll to the top of the page.

News

From the College of Natural Sciences
UT Austin Chemist Livia Eberlin Named a Moore Inventor Fellow

UT Austin Chemist Livia Eberlin Named a Moore Inventor Fellow

Livia Eberlin has been named a Moore Inventor Fellow. Photo courtesy of Moore Foundation.

A foundation that has set a goal this decade of identifying 50 inventors who will shape the next 50 years has added its second University of Texas at Austin faculty member to the list. The Gordon and Betty Moore Foundation announced Livia Eberlin, assistant professor in the Department of Chemistry, is one of this year's five Moore Inventor fellows.

Dave Thirumalai Awarded Langmuir Prize in Chemical Physics

Dave Thirumalai Awarded Langmuir Prize in Chemical Physics

A chemist at the University of Texas at Austin has been awarded the top prize for chemical physics, given biennially by the American Physical Society. Davarajan Thirumalai received the Irving Langmuir Prize in Chemical Physics for his groundbreaking work in developing "analytical and computational approaches to soft-matter systems" and applying these approaches to "the transitional behavior of supercooled fluids and glasses, folding dynamics of protein and RNA biopolymers, and functioning of molecular motors."

‘Honey, I Shrunk the Cell Culture’: Scientists Use Shrink Ray for Biomedical Research

‘Honey, I Shrunk the Cell Culture’: Scientists Use Shrink Ray for Biomedical Research

Using a new kind of "shrink ray", UT Austin scientists can alter the surface of a hydrogel pad in real time, creating grooves (blue) and other patterns without disturbing living cells, such as this fibroblast cell (red) that models the behavior of human skin cells. Rapid appearance of such surface features during cell growth can mimic the dynamic conditions experienced during development and repair of tissue (e.g., in wound healing and nerve regrowth). Credit: Jason Shear/University of Texas at Austin.

From "Fantastic Voyage" to "Despicable Me," shrink rays have been a science-fiction staple on screen. Now chemists at The University of Texas at Austin have developed a real shrink ray that can change the size and shape of a block of gel-like material while human or bacterial cells grow on it. This new tool holds promise for biomedical researchers, including those seeking to shed light on how to grow replacement tissues and organs for implants.

New Protein Sequencing Method Could Transform Biological Research

New Protein Sequencing Method Could Transform Biological Research

An ultra-sensitive new method for identifying the series of amino acids in individual proteins (a.k.a. protein sequencing) can accelerate research on biomarkers for cancer and other diseases. Credit: David Steadman/University of Texas at Austin.

A team of researchers at The University of Texas at Austin has demonstrated a new way to sequence proteins that is much more sensitive than existing technology, identifying individual protein molecules rather than requiring millions of molecules at a time. The advance could have a major impact in biomedical research, making it easier to reveal new biomarkers for the diagnosis of cancer and other diseases, as well as enhance our understanding of how healthy cells function.

Visualizing Science 2018: Beauty and Inspiration in College Research

Visualizing Science 2018: Beauty and Inspiration in College Research

Over the last six years, faculty, staff and students from across the College of Natural Sciences have submitted hundreds of images from their scholarly research for our annual Visualizing Science competition, and these images have been viewed by tens of thousands of people. The submitted images, often beautiful and stunning, are the ones that spoke to their creators, inspiring and informing them as they followed their scientific passions.

MacArthur Foundation Fellows Include UT Austin’s Inventor of ‘Cancer Pen’

MacArthur Foundation Fellows Include UT Austin’s Inventor of ‘Cancer Pen’

Livia S. Eberlin, chemistry professor at the University of Texas at Austin has won a MacArthur "genius award." Photo credit: Wyatt McSpadden/Univ. of Texas at Austin.

Livia Schiavinato Eberlin, an assistant professor of chemistry at The University of Texas at Austin, has won a MacArthur Foundation Fellowship, sometimes called a "genius" award. The prestigious, no-strings-attached five-year fellowship awards $625,000 to each recipient.

Four to Receive Major Awards from Chemical Societies

Four to Receive Major Awards from Chemical Societies

Four chemists (from left to right): Eric Anslyn, Jennifer Brodbelt, Hung-Wen (Ben) Liu, Jonathan Sessler receive major awards. Image Credit: University of Texas at Austin

Four UT Austin faculty members have won major awards for 2019 from the American Chemical Society (ACS) and the International Conference on Calixarenes for their contributions to an array of research areas.

UT Austin Alum James Allison Awarded Nobel Prize

UT Austin Alum James Allison Awarded Nobel Prize

James P. Allison, a world-renowned pioneer of cancer immunotherapy, has been awarded the 2018 Nobel Prize in physiology or medicine jointly with Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation."

CNS Welcomes New Faculty As Fall Semester Begins

CNS Welcomes New Faculty As Fall Semester Begins

With the new academic year in full swing, there are some new faces around the College of Natural Sciences. Meet the 20 new tenured and tenure-track faculty members, whose expertise ranges from astrophysics to nutrition to mathematics.

Making Cancer’s Metabolism More Normal Blocks Drug Resistance

Making Cancer’s Metabolism More Normal Blocks Drug Resistance

Updated on August 31, 2018: This release was updated to correct mistakes in descriptions of the way cancer cells develop drug resistance and the way that anti-cancer drug DCA affects the metabolism of cancer cells.

The chemical structure of C1, a drug combining two active elements: Doxorubicin (Dox), a powerful cancer chemotherapy agent that's been used for decades; and a dichloroacetic acid (DCA) subunit, which reverses a cell's metabolism to aerobic. Credit: University of Texas at Austin

A new drug lead shows promise that it could reduce the size of cancerous tumors much more effectively than current treatments.